Navigation Links
Mayo Clinic researchers find tamoxifen's power comes from endoxifen
Date:12/11/2008

SAN ANTONIO - Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.

Their study, being presented at the Cancer Therapy & Research Center-American Association for Cancer Research (CTRC-AACR) 31st annual San Antonio Breast Cancer Symposium, finds that, in contrast to the other tamoxifen metabolites, endoxifen degrades the estrogen receptor, and inhibits the growth of breast cancer cells even when tamoxifen is present. These new findings are believed to be the most definite laboratory analysis yet on how tamoxifen and its two main metabolites - endoxifen and 4HT (4-hydroxytamoxifen) -act against breast cancer.

"Tens of thousands of women in this country are prescribed tamoxifen for either treatment or prevention of breast cancer, and while it has shown remarkable success, it does not work for a substantial number of patients," says the study's lead investigator, John Hawse, Ph.D. "These findings increase our understanding of tamoxifen and, we hope, could pave the way for improved therapies."

Tamoxifen is designed to treat estrogen-receptor positive breast cancer (70-80 percent of all breast cancer) because this receptor fuels the cancer's growth. But tamoxifen is a "pro-drug," which means that it is relatively inactive until converted into active "metabolites" - the 4HT and endoxifen chemicals that actually perform the work of the drug.

Researchers at Mayo Clinic earlier discovered that tamoxifen is less effective in women who had a deficiency in the enzyme CYP2D6, which is responsible for converting tamoxifen to endoxifen. The CYP2D6 gene is present in different forms in different people. A team of Mayo Clinic investigators, including Matthew Goetz, M.D., Matthew Ames, Ph.D., and James Ingle, M.D., have shown that women with certain
'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New statement outlines essentials of heart failure clinics
2. Preferred Management Corp. Installs OpusClinicalSuite(R) at 2 Texas Hospitals
3. OptumHealth Launched myOptumHealth.com, Health and Wellness Information Destination with Clinically Reviewed Content, Tools and Resources
4. Advanced imaging technology used at Mayo Clinic improves spinal surgery outcome
5. Lifeclinic International and Get Real Consulting Team-Up to Launch Microsoft's HealthVault
6. December 2008 Mayo Clinic Womens HealthSource Highlights Happiness, Dementia and Smoking
7. December 2008 Mayo Clinic Health Letter Highlights: Colorectal Screenings, Lighting Tips for Low Vision and Generic Medications
8. Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy
9. CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations
10. Bio-Imaging Technologies Partners with AG Mednet to Offer Complete Imaging Solution for Clinical Trials : --Partnership Increases Trial Efficiency and Enhances Data Quality--
11. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses and ... collection of wedding dresses , and launches a site-wide women’s ... dress on your big day; the wedding gown is the ... to find the most suitable wedding dress. Now, we are ...
(Date:1/22/2015)... January 22, 2015 Step into a ... the Science Museum of Virginia. Wicked Plants, the Museum’s ... Plants unearths 75 poisonous, carnivorous and diabolical plants inside ... room to uncover the biochemical, physical and neurological processes ...
(Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... , , SOUTH SAN ... ) today reported financial results for the second quarter and six months ... quarter of 2009, Rigel reported a net loss of $29.9 million, or ... $0.93 per share, in the second quarter of 2008. Weighted average shares ...
... , , , , ... BNVI ) today announced positive results from the Phase 1B ... advanced breast cancer. In the trial, Bezielle showed an excellent safety ... a difficult-to-treat population. , , The ...
... , , SPRING, Texas, Aug. 4 ... the nutrition and investing community that its flagship product Cholesterade(R), along ... easily accessible by simply Googling Cholesterade(R). , , ... Go Healthy and/or its products, we are confident that the web ...
... ... resources for children and adults suffering from Food Allergies and Food Intolerance issues. , ... Tampa, FL (PRWEB) August 4, 2009 ... adults in the United States. Scientists estimate over 12 million Americans suffer from Food Allergies. ...
... , , ... Ashes is played out on the cricket pitch, 2,000 English ... their prowess and behaviours at the barbecue in a poll* ... ( http://nutritionandfitness.axappphealthcare.co.uk/index.php?axacmp=pr/articles/bbq ) Despite the ...
... , , IRVINE, Calif., Aug. 4 ... of $0.49 for the quarter ended June 30, 2009, a 24% increase ... Company reported quarterly revenues of $81 million, a 4% increase compared to ... , The Company,s results are reflective of improved growth in ...
Cached Medicine News:Health News:Rigel Announces Second Quarter 2009 Financial Results 2Health News:Rigel Announces Second Quarter 2009 Financial Results 3Health News:Rigel Announces Second Quarter 2009 Financial Results 4Health News:Rigel Announces Second Quarter 2009 Financial Results 5Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 2Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 3Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 4Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 5Health News:Go Healthy's Marquis Product Cholesterade(R) at Your Fingertips on Google 2Health News:New Online Solution for Food Allergy Sufferers. Allergiesandme.com Provides Needed Resources 2Health News:Survey Compares Aussie and English Barbeque Attitudes 2Health News:Survey Compares Aussie and English Barbeque Attitudes 3Health News:CorVel Announces Revenues and Earnings 2Health News:CorVel Announces Revenues and Earnings 3Health News:CorVel Announces Revenues and Earnings 4Health News:CorVel Announces Revenues and Earnings 5
(Date:1/22/2015)... Inc. (NYSE: RMD ) today announced results for ... was $423.0 million, a 10 percent increase compared to the ... a constant currency basis). Net income was $91.2 million, an ... 31, 2013. Diluted earnings per share for the quarter were ...
(Date:1/22/2015)... 22, 2015  Amgen (NASDAQ: AMGN ) today announced that ... results on Tuesday, Jan. 27, 2015, after the close of the ... call with the investment community at 2 p.m. PT. Participating in ... chairman and chief executive officer, and other members of Amgen,s senior ...
(Date:1/22/2015)... Institute for Clinical Research, Inc., a clinical research organization ... new textbook,  Translational Research Methods for Diabetes, Obesity and ... scientific publisher. The textbook is the first ... early phase clinical studies of new drugs for diabetes, ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company ... patients, today announced that, as anticipated, on November 30, 2010, ... (the "Staff") of The NASDAQ Stock Market (the "Staff Determination") ... compliance with the $1.00 minimum bid price requirement, as set ...
... Unilife Corporation ( Unilife or Company ) (Nasdaq: ... completed the A$23.1 million private placement ( Placement ), which was ... 27,228,143 CHESS Depositary Interests ( CDIs ) ( Placement CDIs ) ... in one sixth of a share of the Company,s common stock) ...
Cached Medicine Technology:Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing 2Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing 3Unilife Completes A$23.1 Million Private Placement 2Unilife Completes A$23.1 Million Private Placement 3Unilife Completes A$23.1 Million Private Placement 4Unilife Completes A$23.1 Million Private Placement 5
... IEC CL30 Series from Thermo ... value for your low-speed clinical ... rotor exchange system, user-friendly controls, ... IEC CL30 Series delivers solid ...
... and FL40 Centrifuge Series from Thermo ... to increase your productivity in the ... of rotors and accessories for high-volume ... the IEC CL40 and FL40 Centrifuge ...
... CL10 from Thermo is ... your low-speed clinical applications. ... of rotors, user-friendly controls, ... the IEC CL10 delivers ...
Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1 / 2, HIV 1/ 2 STAT-PAK and HIV 1/ 2 STAT-PAK Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of anti...
Medicine Products: